吉利德科学(GILD)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

GILD 吉利德科学

未开盘 08-08 16:00:00 EDT

119.41

+9.13

+8.28%

盘后119.05

-0.36-0.30%

19:56 EDT

最高121.38	最低114.80	成交量1,312万
今开115.22	昨收110.28	日振幅5.97%
总市值1,482亿	流通市值1,479亿	总股本12.41亿
成交额15.65亿	换手率1.06%	流通股本12.38亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"GILD","market":"US","secType":"STK","nameCN":"吉利德科学","latestPrice":119.41,"timestamp":1754683200000,"preClose":110.28,"halted":0,"volume":13115287,"hourTrading":{"tag":"盘后","latestPrice":119.05,"preClose":119.41,"latestTime":"19:56 EDT","volume":2777376,"amount":331647118.4327,"timestamp":1754697398229},"delay":0,"floatShares":1238242292,"shares":1240806916,"eps":5.011126,"marketStatus":"未开盘","change":9.13,"latestTime":"08-08 16:00:00 EDT","open":115.22,"high":121.38,"low":114.8,"amount":1565109364.1703799,"amplitude":0.059666,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":5.011126,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1754899200000},"marketStatusCode":0,"adr":0,"adrRate":0,"listingDate":696056400000,"exchange":"NASDAQ","adjPreClose":110.28,"dividendRate":0.026128,"preHourTrading":{"tag":"盘前","latestPrice":115.74,"preClose":110.28,"latestTime":"09:25 EDT","volume":30554,"amount":3524606.77856,"timestamp":1754659551383},"postHourTrading":{"tag":"盘后","latestPrice":119.05,"preClose":119.41,"latestTime":"19:56 EDT","volume":2777376,"amount":331647118.4327,"timestamp":1754697398229},"volumeRatio":1.962204509931319,"impliedVol":0.2655,"impliedVolPercentile":0.1606},"requestUrl":"/m/hq/s/GILD","defaultTab":"news","newsList":[{"id":"2558334446","title":"吉利德：重仓多年的CAR-T仍无法挑起大梁，营收依然高度依赖艾滋病业务","url":"https://stock-news.laohu8.com/highlight/detail?id=2558334446","media":"动脉网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558334446?lang=zh_cn&edition=full","pubTime":"2025-08-11 09:55","pubTimestamp":1754877300,"startTime":"0","endTime":"0","summary":"吉利德科学在2025年第二季度的财务业绩显示，尽管整体营收仅增长2%，但其核心HIV业务表现强劲，特别是Biktarvy和Descovy销售额分别增长9%和35%。HIV产品销售额达51亿美元，占总营收的72%。然而，新冠药物Veklury和细胞疗法产品的销售持续下滑。公司上调了全年营收和盈利指引，并宣布了新的60亿美元股票回购计划，显示出对未来增长的信心。此外，FDA批准了吉利德新药Yeztugo，成为全球首款半年一次的HIV暴露前预防方案，预计下半年上市。尽管面临挑战，吉利德仍通过核心业务的稳健表现和新产品的推出保持了市场地位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250811104036973ff6e7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250811104036973ff6e7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GILD","CAR"],"gpt_icon":0},{"id":"2558032265","title":"吉利德科学8月8日成交额为15.65亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2558032265","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558032265?lang=zh_cn&edition=full","pubTime":"2025-08-09 10:34","pubTimestamp":1754706846,"startTime":"0","endTime":"0","summary":"美东时间2025年8月8日，吉利德科学成交额为15.65亿美元，成交额较昨日增加55.04%，当日成交量为1311.53万股。吉利德科学于2025年8月8日涨8.28%，报119.41美元，该股过去5个交易日涨5.5%，年初至今涨31.12%，过去60日涨18.57%。吉利德对Pharmasset的收购带来了丙型肝炎药物索磷布韦片的使用权，该药物也是仍为治疗标准的较新的联合方案的一部分。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250809103416a6dbf2a8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250809103416a6dbf2a8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE0002270589.USD","LU1585245621.USD","BK4585","BK4583","LU0889565916.HKD","LU1571399168.USD","LU1674673691.USD","LU0234570918.USD","LU2468319806.SGD","IE00BSNM7G36.USD","IE00B19Z3B42.SGD","LU1778281490.HKD","BK4139","LU2087621335.USD","GILD","LU0289739699.SGD","BK4532","BK4550","IE00B7SZLL34.SGD","LU1066053197.SGD","LU1674673428.USD","LU1839511570.USD","IE00BZ1G4Q59.USD","LU2089984988.USD","SG9999015986.USD","LU0058720904.USD","IE00B19Z3581.USD","LU0320765992.SGD","LU2324357040.USD","LU1066051498.USD","BK4568","LU1430594728.SGD","LU0109394709.USD","IE00B3T34201.USD","IE00BKVL7J92.USD","LU0823416689.USD","BK4588","SG9999015945.SGD","BK4578","SG9999015952.SGD","SG9999015978.USD","BK4566"],"gpt_icon":0},{"id":"2557060578","title":"美股异动 | 吉利德科学(GILD.US)涨近9% Q2业绩超预期并上调年度指引","url":"https://stock-news.laohu8.com/highlight/detail?id=2557060578","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557060578?lang=zh_cn&edition=full","pubTime":"2025-08-08 22:42","pubTimestamp":1754664135,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"97c2ffd8fa7eb1417bc669fbbcace331","theme_name":"🔥热榜No.30 · 吉利德科学二季度业绩超预期，股价大涨","theme_type":2,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4588","LU0058720904.USD","BK4550","LU1585245621.USD","LU2089984988.USD","LU2468319806.SGD","BK4583","LU0320765992.SGD","LU0823416689.USD","BK4139","IE00BSNM7G36.USD","LU0289739699.SGD","IE0002270589.USD","LU1066053197.SGD","SG9999015986.USD","LU1430594728.SGD","BK4568","BK4566","IE00BKVL7J92.USD","IE00BZ1G4Q59.USD","BK4532","IE00B19Z3B42.SGD","LU2324357040.USD","BK4578","IE00B19Z3581.USD","LU1778281490.HKD","SG9999015945.SGD","LU0889565916.HKD","SG9999015952.SGD","LU1571399168.USD","LU1066051498.USD","IE00B7SZLL34.SGD","BK4585","IE00B3T34201.USD","SG9999015978.USD","LU0109394709.USD","LU1674673691.USD","LU0234570918.USD","LU1674673428.USD","GILD","LU1839511570.USD","LU2087621335.USD"],"gpt_icon":0},{"id":"1143076540","title":"吉利德科学涨超8%，二季度业绩超预期，创历史新高","url":"https://stock-news.laohu8.com/highlight/detail?id=1143076540","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1143076540?lang=zh_cn&edition=full","pubTime":"2025-08-08 21:57","pubTimestamp":1754661466,"startTime":"0","endTime":"0","summary":"8月8日（周五），吉利德科学涨超8%，二季度业绩超预期，创历史新高消息方面：吉利德科学公布财报显示，2025年第二季度营业收入增长2%至70.8亿美元，超市场预期的69.8亿美元；调整后的每股收益为2.01美元，高于市场预期的1.96美元。","market":"us","thumbnail":"https://static.tigerbbs.com/42ad05de22d96b714ae597f00bdbeaa5","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/42ad05de22d96b714ae597f00bdbeaa5"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"97c2ffd8fa7eb1417bc669fbbcace331","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GILD"],"gpt_icon":0},{"id":"1129863308","title":"异动解读 | 吉利德科学盘中大涨8.05%，业绩超预期及新药前景乐观推动股价","url":"https://stock-news.laohu8.com/highlight/detail?id=1129863308","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1129863308?lang=zh_cn&edition=full","pubTime":"2025-08-08 21:52","pubTimestamp":1754661150,"startTime":"0","endTime":"0","summary":"周五盘中，$吉利德科学$股价大涨8.05%，引发投资者广泛关注。此次显著上涨主要受到公司发布的强劲财报以及分析师对其新药的积极评价推动。根据吉利德科学公布的2025年第二季度财报，公司实现调整后每股收益2.01美元，超过分析师预期的1.96美元。此外，华尔街分析师对吉利德科学新推出的艾滋病预防药物Yeztugo持乐观态度。这些积极因素共同推动了吉利德科学股价的大幅上涨，反映出投资者对公司未来发展前景的信心增强。","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"97c2ffd8fa7eb1417bc669fbbcace331","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["GILD"],"gpt_icon":1},{"id":"2557520879","title":"吉利德科学股价一度上涨10%至2015年以来最高。","url":"https://stock-news.laohu8.com/highlight/detail?id=2557520879","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557520879?lang=zh_cn&edition=full","pubTime":"2025-08-08 21:42","pubTimestamp":1754660544,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"97c2ffd8fa7eb1417bc669fbbcace331","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU0234570918.USD","LU2087621335.USD","LU1066053197.SGD","BK4585","IE00BZ1G4Q59.USD","BK4583","LU1839511570.USD","IE00BSNM7G36.USD","LU1430594728.SGD","BK4550","SG9999015945.SGD","LU1066051498.USD","SG9999015978.USD","LU1571399168.USD","IE00B19Z3581.USD","IE00B19Z3B42.SGD","IE00BKVL7J92.USD","BK4532","BK4578","LU1778281490.HKD","IE00B7SZLL34.SGD","LU0109394709.USD","LU0823416689.USD","GILD","LU0289739699.SGD","SG9999015952.SGD","LU0058720904.USD","LU2089984988.USD","BK4566","LU0320765992.SGD","LU1674673428.USD","LU0889565916.HKD","SG9999015986.USD","LU1585245621.USD","LU1674673691.USD","BK4588","BK4568","BK4139","LU2324357040.USD","IE00B3T34201.USD","LU2468319806.SGD","IE0002270589.USD"],"gpt_icon":0},{"id":"1194379760","title":"异动解读 | 吉利德科学盘前大涨5.24%，二季度业绩超预期且新药前景乐观","url":"https://stock-news.laohu8.com/highlight/detail?id=1194379760","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1194379760?lang=zh_cn&edition=full","pubTime":"2025-08-08 19:42","pubTimestamp":1754653352,"startTime":"0","endTime":"0","summary":"吉利德科学今日盘前大涨5.24%，引发投资者关注。这一涨幅主要源于公司发布的强劲财报以及分析师对其新药的积极评价。根据公司公布的2025年第二季度财报，吉利德科学实现调整后每股收益2.01美元，超过分析师预期的1.96美元。季度收入同比增长2%至70.8亿美元，同样高于市场预期的69.8亿美元。此外，华尔街分析师对吉利德科学新推出的艾滋病预防药物Yeztugo持乐观态度。这些积极因素共同推动了吉利德科学股价的大幅上涨。","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"97c2ffd8fa7eb1417bc669fbbcace331","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["GILD"],"gpt_icon":0},{"id":"2557449675","title":"吉利德科学(GILD.US)美股盘前涨2.9%。消息上吉利德科学周四公布的第二季度利润为19.6亿美元合每股1.56美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2557449675","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557449675?lang=zh_cn&edition=full","pubTime":"2025-08-08 17:06","pubTimestamp":1754643962,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU0289739699.SGD","IE00B3T34201.USD","LU1571399168.USD","BK4568","LU1778281490.HKD","LU2468319806.SGD","LU0823416689.USD","LU2087621335.USD","LU1674673691.USD","LU0058720904.USD","GILD","BK4588","LU1430594728.SGD","IE00B19Z3581.USD","SG9999015986.USD","IE00B19Z3B42.SGD","LU1066053197.SGD","LU2324357040.USD","LU2089984988.USD","LU1839511570.USD","LU0234570918.USD","LU1066051498.USD","BK4585","BK4578","LU1585245621.USD","LU0109394709.USD","BK4566","BK4139","BK4532","BK4550","IE00B7SZLL34.SGD","SG9999015978.USD","IE00BKVL7J92.USD","LU1674673428.USD","BK4583","LU0889565916.HKD","SG9999015945.SGD","IE00BSNM7G36.USD","LU0320765992.SGD","SG9999015952.SGD","IE00BZ1G4Q59.USD","IE0002270589.USD"],"gpt_icon":0},{"id":"2557554624","title":"吉利德科学二季度非瑞德西韦产品销售额增长4%","url":"https://stock-news.laohu8.com/highlight/detail?id=2557554624","media":"DoNews","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557554624?lang=zh_cn&edition=full","pubTime":"2025-08-08 15:44","pubTimestamp":1754639043,"startTime":"0","endTime":"0","summary":"吉利德科学公司近日公布2025年第二季度财务数据，除去抗病毒药物瑞德西韦的销售额，公司其他产品销售额同比增长4%。数据显示，瑞德西韦在本季度的销售额同比下降，但公司其他主要产品线表现出稳定增长。吉利德科学表示，这一增长主要得益于其在肿瘤学、免疫学和抗病毒治疗领域的核心产品持续获得市场认可。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250808155240973b58d3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250808155240973b58d3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4578","LU1674673691.USD","IE0002270589.USD","LU1430594728.SGD","LU1066053197.SGD","LU0320765992.SGD","LU0823416689.USD","BK4583","BK4532","BK4550","SG9999015945.SGD","LU0058720904.USD","LU1778281490.HKD","LU1571399168.USD","IE00BKVL7J92.USD","SG9999015978.USD","LU2089984988.USD","IE00BSNM7G36.USD","IE00B19Z3581.USD","LU1674673428.USD","BK4139","IE00B3T34201.USD","LU0889565916.HKD","LU2324357040.USD","IE00B7SZLL34.SGD","SG9999015952.SGD","BK4566","LU1585245621.USD","BK4568","BK4585","LU2087621335.USD","SG9999015986.USD","BK4588","LU2468319806.SGD","GILD","LU0109394709.USD","LU0289739699.SGD","LU1066051498.USD","IE00B19Z3B42.SGD","IE00BZ1G4Q59.USD","LU0234570918.USD","LU1839511570.USD"],"gpt_icon":0},{"id":"2557545878","title":"8月8日吉利德科学发布2025年第二季度财务报告：产品销售额（除瑞德西韦外）同比增长4%达69亿美元。其中必妥维销售额同","url":"https://stock-news.laohu8.com/highlight/detail?id=2557545878","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557545878?lang=zh_cn&edition=full","pubTime":"2025-08-08 15:18","pubTimestamp":1754637496,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4583","BK4566","LU1778281490.HKD","LU1585245621.USD","LU2087621335.USD","LU1571399168.USD","LU0289739699.SGD","LU0889565916.HKD","LU1066051498.USD","GILD","LU1839511570.USD","BK4550","IE00B3T34201.USD","LU2324357040.USD","BK4578","IE00BZ1G4Q59.USD","LU1066053197.SGD","SG9999015952.SGD","LU0109394709.USD","SG9999015978.USD","IE00B7SZLL34.SGD","BK4139","LU1674673428.USD","IE00B19Z3B42.SGD","LU0234570918.USD","LU0320765992.SGD","BK4532","LU2089984988.USD","LU0058720904.USD","LU1430594728.SGD","IE0002270589.USD","LU2468319806.SGD","IE00BKVL7J92.USD","SG9999015986.USD","BK4585","LU1674673691.USD","BK4588","LU0823416689.USD","IE00B19Z3581.USD","BK4568","IE00BSNM7G36.USD","SG9999015945.SGD"],"gpt_icon":0},{"id":"2557516195","title":"吉利德科学8月7日成交额为10.09亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2557516195","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557516195?lang=zh_cn&edition=full","pubTime":"2025-08-08 10:32","pubTimestamp":1754620343,"startTime":"0","endTime":"0","summary":"美东时间2025年8月7日，吉利德科学成交额为10.09亿美元，成交额较昨日增加22.40%，当日成交量为919.03万股。吉利德科学于2025年8月7日涨0.0%，报110.28美元，该股过去5个交易日跌1.79%，年初至今涨21.09%，过去60日涨6.98%。吉利德对Pharmasset的收购带来了丙型肝炎药物索磷布韦片的使用权，该药物也是仍为治疗标准的较新的联合方案的一部分。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250808103230a6d9f0aa&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250808103230a6d9f0aa&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE00B7SZLL34.SGD","LU2087621335.USD","LU0889565916.HKD","LU2468319806.SGD","BK4139","BK4583","LU1839511570.USD","LU2324357040.USD","LU0320765992.SGD","IE00B3T34201.USD","LU1778281490.HKD","BK4585","SG9999015945.SGD","LU0289739699.SGD","IE00B19Z3581.USD","SG9999015952.SGD","IE00B19Z3B42.SGD","LU0823416689.USD","SG9999015978.USD","LU1066053197.SGD","BK4550","BK4568","LU1674673691.USD","IE00BZ1G4Q59.USD","BK4566","IE00BKVL7J92.USD","IE0002270589.USD","LU1066051498.USD","LU1430594728.SGD","LU2089984988.USD","SG9999015986.USD","LU1674673428.USD","LU0234570918.USD","LU1585245621.USD","BK4578","IE00BSNM7G36.USD","LU0109394709.USD","GILD","BK4588","LU0058720904.USD","LU1571399168.USD","BK4532"],"gpt_icon":0},{"id":"2555064777","title":"特朗普拟对进口药品征收高额关税，谁最可能受影响？","url":"https://stock-news.laohu8.com/highlight/detail?id=2555064777","media":"智通财经网","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555064777?lang=zh_cn&edition=full","pubTime":"2025-07-30 13:40","pubTimestamp":1753854000,"startTime":"0","endTime":"0","summary":"7月30日，美国总统特朗普即将对进口药品加征关税，这一政策可能最快于8月1日开始实施，并在未来一年或一年半内逐步提高税率。包括罗氏在内的多家药企高管近期对药品关税提出强烈批评，认为该政策将损害研发投入，并最终导致患者可获得的治疗选择减少。罗氏强调，药品和诊断应被排除在关税之外，以保护患者可及性和未来的医疗创新。但公司也表示，已做好准备应对潜在关税，通过库存调整等方式确保产品供应不受影响。","market":"us","thumbnail":"https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1323364.html","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"特朗普拟对进口药品征收高额关税，谁最可能受影响？","news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["BK4535","LLY","NVO","MRK","ZTS","BK4023","GSK","PFE","BK4551","BMY","NVS","SNY","AZN","RHHBY","GILD","BIIB","VRTX","BK4503","AMGN"],"gpt_icon":1},{"id":"2555099308","title":"吉利德科学7月29日成交额为7.15亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2555099308","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555099308?lang=zh_cn&edition=full","pubTime":"2025-07-30 10:28","pubTimestamp":1753842528,"startTime":"0","endTime":"0","summary":"美东时间2025年7月29日，吉利德科学成交额为7.15亿美元，成交额较昨日增加17.24%，当日成交量为627.89万股。吉利德科学于2025年7月29日涨1.06%，报114.23美元，该股过去5个交易日涨3.69%，年初至今涨25.43%，过去60日涨11.43%。吉利德对Pharmasset的收购带来了丙型肝炎药物索磷布韦片的使用权，该药物也是仍为治疗标准的较新的联合方案的一部分。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250730102850a6c8c7de&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250730102850a6c8c7de&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4588","LU0058720904.USD","BK4550","LU1585245621.USD","LU2089984988.USD","LU2468319806.SGD","BK4583","LU0320765992.SGD","LU0823416689.USD","BK4139","IE00BSNM7G36.USD","LU0289739699.SGD","IE0002270589.USD","LU1066053197.SGD","SG9999015986.USD","LU1430594728.SGD","BK4568","BK4566","IE00BKVL7J92.USD","IE00BZ1G4Q59.USD","BK4532","IE00B19Z3B42.SGD","LU2324357040.USD","BK4578","IE00B19Z3581.USD","LU1778281490.HKD","SG9999015945.SGD","LU0889565916.HKD","SG9999015952.SGD","LU1571399168.USD","LU1066051498.USD","IE00B7SZLL34.SGD","BK4585","IE00B3T34201.USD","SG9999015978.USD","LU0109394709.USD","LU1674673691.USD","LU0234570918.USD","LU1674673428.USD","GILD","LU1839511570.USD","LU2087621335.USD"],"gpt_icon":0},{"id":"2554772927","title":"吉利德科学盘中异动 早盘股价大跌3.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2554772927","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2554772927?lang=zh_cn&edition=full","pubTime":"2025-07-28 21:31","pubTimestamp":1753709504,"startTime":"0","endTime":"0","summary":"北京时间2025年07月28日21时31分，吉利德科学股票出现波动，股价快速跳水3.00%。截至发稿，该股报112.71美元/股，成交量17.8378万股，换手率0.01%，振幅1.08%。吉利德科学股票所在的制药行业中，整体涨幅为0.16%。吉利德科学公司简介：吉利德科学开发和营销用于治疗威胁生命的传染病的疗法，其投资组合的核心集中在艾滋病毒，乙型和丙型肝炎。吉利德对Pharmasset的收购带来了丙型肝炎药物索磷布韦片的使用权，该药物也是仍为治疗标准的较新的联合方案的一部分。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250728213144a467d987&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250728213144a467d987&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0234570918.USD","LU2087621335.USD","LU1066053197.SGD","BK4585","IE00BZ1G4Q59.USD","BK4583","LU1839511570.USD","IE00BSNM7G36.USD","LU1430594728.SGD","BK4550","SG9999015945.SGD","LU1066051498.USD","SG9999015978.USD","LU1571399168.USD","IE00B19Z3581.USD","IE00B19Z3B42.SGD","IE00BKVL7J92.USD","BK4532","BK4578","LU1778281490.HKD","IE00B7SZLL34.SGD","LU0109394709.USD","LU0823416689.USD","GILD","LU0289739699.SGD","SG9999015952.SGD","LU0058720904.USD","LU2089984988.USD","BK4566","LU0320765992.SGD","LU1674673428.USD","LU0889565916.HKD","SG9999015986.USD","LU1585245621.USD","LU1674673691.USD","BK4588","BK4568","BK4139","LU2324357040.USD","IE00B3T34201.USD","LU2468319806.SGD","IE0002270589.USD"],"gpt_icon":0},{"id":"2554718070","title":"吉利德科学7月25日成交额为8.93亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2554718070","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2554718070?lang=zh_cn&edition=full","pubTime":"2025-07-26 10:25","pubTimestamp":1753496747,"startTime":"0","endTime":"0","summary":"美东时间2025年7月25日，吉利德科学成交额为8.93亿美元，成交额较昨日增加92.15%，当日成交量为768.08万股。吉利德科学于2025年7月25日涨2.65%，报116.2美元，该股过去5个交易日涨7.37%，年初至今涨27.59%，过去60日涨12.3%。吉利德对Pharmasset的收购带来了丙型肝炎药物索磷布韦片的使用权，该药物也是仍为治疗标准的较新的联合方案的一部分。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250726102552a6c27cf9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250726102552a6c27cf9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE00B7SZLL34.SGD","BK4588","IE00B3T34201.USD","IE00BSNM7G36.USD","LU1066051498.USD","GILD","LU2468319806.SGD","LU1585245621.USD","BK4578","BK4550","LU0889565916.HKD","LU1674673691.USD","LU1571399168.USD","LU1778281490.HKD","LU2324357040.USD","LU0109394709.USD","SG9999015952.SGD","IE00B19Z3581.USD","BK4566","SG9999015986.USD","LU1066053197.SGD","LU2089984988.USD","BK4585","LU1674673428.USD","BK4583","LU2087621335.USD","BK4139","LU0320765992.SGD","LU0289739699.SGD","LU1430594728.SGD","LU0234570918.USD","IE00B19Z3B42.SGD","SG9999015945.SGD","BK4568","BK4532","SG9999015978.USD","IE0002270589.USD","IE00BKVL7J92.USD","IE00BZ1G4Q59.USD","LU1839511570.USD","LU0058720904.USD","LU0823416689.USD"],"gpt_icon":0},{"id":"2554795973","title":"吉利德科学升2.3% 公司HIV预防药获CHMP加速审批","url":"https://stock-news.laohu8.com/highlight/detail?id=2554795973","media":"金吾资讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2554795973?lang=zh_cn&edition=full","pubTime":"2025-07-25 22:59","pubTimestamp":1753455573,"startTime":"0","endTime":"0","summary":"金吾财讯 | 吉利德科学(GILD)股价上扬，截至发稿，涨2.31%，报115.81美元。公司今日宣布，欧洲药品管理局（EMA）下属人用药品委员会（CHMP）已通过加速审评程序出具积极审评意见，推荐该公司HIV-1衣壳抑制剂注射剂lenacapavir用于暴露前预防（PrEP），以降低存在HIV-1感染风险的成年及青少年群体经性行为感染该病毒的概率。最终审批决定预计于今年晚些时间公布，若获批上市，该药物将以商品名Yeytuo®在欧盟地区销售。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025072523004094bad418&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025072523004094bad418&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4566","LU1430594728.SGD","SG9999015986.USD","LU2468319806.SGD","IE00B3T34201.USD","SG9999015945.SGD","LU1066053197.SGD","IE0002270589.USD","SG9999015978.USD","IE00B19Z3B42.SGD","BK4578","BK4087","LU0058720904.USD","LU0289739699.SGD","IE00BSNM7G36.USD","IE00BZ1G4Q59.USD","LU0234570918.USD","BK4583","LU1674673428.USD","BK4532","LU2087621335.USD","LU2324357040.USD","LU1571399168.USD","GILD","LU0889565916.HKD","SG9999015952.SGD","LU1585245621.USD","BK4550","IE00B7SZLL34.SGD","CHMP","IE00BKVL7J92.USD","LU1839511570.USD","LU1066051498.USD","LU1674673691.USD","BK4568","LU2089984988.USD","BK4585","LU0823416689.USD","IE00B19Z3581.USD","LU1778281490.HKD","BK4139","LU0109394709.USD","BK4588","LU0320765992.SGD"],"gpt_icon":0},{"id":"2554307737","title":"吉利德科学7月24日成交额为4.65亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2554307737","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2554307737?lang=zh_cn&edition=full","pubTime":"2025-07-25 10:20","pubTimestamp":1753410014,"startTime":"0","endTime":"0","summary":"美东时间2025年7月24日，吉利德科学成交额为4.65亿美元，成交额较昨日减少21.30%，当日成交量为410.37万股。吉利德科学于2025年7月24日跌0.32%，报113.2美元，该股过去5个交易日涨4.04%，年初至今涨24.3%，过去60日涨7.21%。吉利德对Pharmasset的收购带来了丙型肝炎药物索磷布韦片的使用权，该药物也是仍为治疗标准的较新的联合方案的一部分。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250725102023a6c0a6e9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250725102023a6c0a6e9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4550","BK4588","IE00BZ1G4Q59.USD","GILD","LU2468319806.SGD","LU2087621335.USD","LU2089984988.USD","LU2324357040.USD","BK4532","BK4585","IE00B7SZLL34.SGD","LU0320765992.SGD","IE0002270589.USD","LU0289739699.SGD","SG9999015978.USD","BK4583","LU1066051498.USD","IE00BSNM7G36.USD","LU0234570918.USD","LU0889565916.HKD","LU1430594728.SGD","LU1571399168.USD","IE00BKVL7J92.USD","LU1585245621.USD","BK4568","BK4139","SG9999015952.SGD","IE00B19Z3B42.SGD","LU1839511570.USD","LU1778281490.HKD","SG9999015945.SGD","LU1674673691.USD","LU0058720904.USD","IE00B3T34201.USD","LU1674673428.USD","LU1066053197.SGD","LU0823416689.USD","SG9999015986.USD","LU0109394709.USD","BK4566","IE00B19Z3581.USD","BK4578"],"gpt_icon":0},{"id":"2553291214","title":"诺奖转化公司的终局","url":"https://stock-news.laohu8.com/highlight/detail?id=2553291214","media":"生物制药小编","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2553291214?lang=zh_cn&edition=full","pubTime":"2025-07-23 14:05","pubTimestamp":1753250717,"startTime":"0","endTime":"0","summary":"近日，Hookipa Pharma这家曾经的诺奖转化公司似乎迎来了这家公司的最终结局——退市被股东吉利德收购。最初的诺奖光环Hookipa Pharma是一家以沙粒病毒平台技术为核心的Biotech，有着诺奖得主创立公司的光环加持。2024年年中，公司实施反向股票分割以避免退市，但现金流仅剩6000万美元，只能依靠吉利德的里程碑付款苟活。2024年7月，公司又宣布以全股票交易方式收购罕见病公司Poolbeg Pharma，并计划发起3000万美元私募融资，但最终放弃收购。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250723141100a6bc8c57&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250723141100a6bc8c57&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1917777945.USD","SG9999015978.USD","LU2023250504.SGD","LU1941712348.USD","LU1699723380.USD","LU0320765489.SGD","LU2361044949.HKD","SG9999014567.USD","LU1941712264.USD","LU0889565916.HKD","IE00B19Z3B42.SGD","LU1093756325.SGD","BK4550","IE00BN8TJ469.HKD","SG9999001176.USD","LU0238689110.USD","LU1035773651.USD","BK4568","GILD","BK4559","LU1674673428.USD","IE00BLSP4239.USD","IE00B1BXHZ80.USD","LU0265550359.USD","LU2089984988.USD","IE00BJT1NW94.SGD","LU0965509010.AUD","LU0006306889.USD","SGXZ57979304.SGD","IE0002141913.USD","IE00B2B36J28.USD","LU0122379950.USD","LU0234570918.USD","SG9999015945.SGD","LU1061106388.HKD","LU1430594728.SGD","MRK","LU0070302665.USD","LU0965509283.SGD","IE00BKVL7J92.USD","IE00BJJMRZ35.SGD","LU1066051811.HKD","LU0106261372.USD","LU0823416689.USD","LU0861579265.USD","LU1162221912.USD","LU1983299246.USD","BK4139","BK4583","LU0234572021.USD"],"gpt_icon":0},{"id":"2553860262","title":"吉利德科学7月21日成交额为3.88亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2553860262","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2553860262?lang=zh_cn&edition=full","pubTime":"2025-07-22 10:20","pubTimestamp":1753150845,"startTime":"0","endTime":"0","summary":"美东时间2025年7月21日，吉利德科学成交额为3.88亿美元，成交额较昨日减少46.12%，当日成交量为357.38万股。吉利德科学于2025年7月21日涨0.06%，报108.28美元，该股过去5个交易日跌3.4%，年初至今涨18.89%，过去60日涨2.51%。吉利德对Pharmasset的收购带来了丙型肝炎药物索磷布韦片的使用权，该药物也是仍为治疗标准的较新的联合方案的一部分。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250722102054a45afac7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250722102054a45afac7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1066051498.USD","LU0058720904.USD","IE00BZ1G4Q59.USD","LU0234570918.USD","BK4585","BK4568","LU2087621335.USD","LU0823416689.USD","LU0889565916.HKD","IE0002270589.USD","IE00B7SZLL34.SGD","IE00BKVL7J92.USD","IE00B3T34201.USD","LU1674673691.USD","BK4550","IE00B19Z3B42.SGD","LU1778281490.HKD","LU2468319806.SGD","SG9999015978.USD","IE00B19Z3581.USD","LU0289739699.SGD","LU1571399168.USD","BK4583","GILD","LU1066053197.SGD","BK4578","BK4588","LU1674673428.USD","SG9999015945.SGD","BK4566","LU1585245621.USD","BK4139","LU1430594728.SGD","LU1839511570.USD","LU0109394709.USD","LU2324357040.USD","SG9999015952.SGD","LU0320765992.SGD","BK4532","SG9999015986.USD","LU2089984988.USD","IE00BSNM7G36.USD"],"gpt_icon":0},{"id":"2552562654","title":"吉利德科学7月17日成交额为4.66亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2552562654","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2552562654?lang=zh_cn&edition=full","pubTime":"2025-07-18 10:18","pubTimestamp":1752805100,"startTime":"0","endTime":"0","summary":"美东时间2025年7月17日，吉利德科学成交额为4.66亿美元，成交额较昨日增加7.09%，当日成交量为427.60万股。吉利德科学于2025年7月17日跌0.96%，报108.8美元，该股过去5个交易日跌5.01%，年初至今涨19.47%，过去60日涨5.03%。吉利德对Pharmasset的收购带来了丙型肝炎药物索磷布韦片的使用权，该药物也是仍为治疗标准的较新的联合方案的一部分。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250718101826a4524746&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250718101826a4524746&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0823416689.USD","LU0109394709.USD","BK4550","LU0320765992.SGD","LU1674673691.USD","LU0058720904.USD","BK4532","LU0889565916.HKD","BK4566","LU2087621335.USD","LU1778281490.HKD","LU2089984988.USD","LU1066053197.SGD","IE00B19Z3581.USD","LU1571399168.USD","GILD","IE0002270589.USD","IE00B7SZLL34.SGD","IE00B3T34201.USD","LU1839511570.USD","LU1066051498.USD","SG9999015952.SGD","BK4139","BK4588","BK4583","LU2324357040.USD","LU2468319806.SGD","SG9999015986.USD","LU0289739699.SGD","IE00BSNM7G36.USD","LU1674673428.USD","LU1585245621.USD","BK4585","SG9999015945.SGD","IE00BKVL7J92.USD","IE00BZ1G4Q59.USD","SG9999015978.USD","BK4578","BK4568","LU1430594728.SGD","LU0234570918.USD","IE00B19Z3B42.SGD"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.gilead.com","stockEarnings":[{"period":"1week","weight":0.055},{"period":"1month","weight":0.0545},{"period":"3month","weight":0.2322},{"period":"6month","weight":0.2433},{"period":"1year","weight":0.5797},{"period":"ytd","weight":0.2927}],"compareEarnings":[{"period":"1week","weight":0.0249},{"period":"1month","weight":0.021},{"period":"3month","weight":0.1291},{"period":"6month","weight":0.0606},{"period":"1year","weight":0.2008},{"period":"ytd","weight":0.0872}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"吉利德科学公司于1987年6月22日在特拉华州成立，是一家以研究为基础的生物制药公司，致力于发现，开发和商业化未满足医疗需求的创新药物。该公司的主要重点领域包括病毒性疾病，炎性和纤维化疾病以及肿瘤学。","yearOnYearQuotes":[{"month":1,"riseRate":0.575758,"avgChangeRate":0.041534},{"month":2,"riseRate":0.411765,"avgChangeRate":0.007165},{"month":3,"riseRate":0.529412,"avgChangeRate":-0.009708},{"month":4,"riseRate":0.529412,"avgChangeRate":0.011973},{"month":5,"riseRate":0.558824,"avgChangeRate":0.0204},{"month":6,"riseRate":0.647059,"avgChangeRate":0.025673},{"month":7,"riseRate":0.558824,"avgChangeRate":0.01609},{"month":8,"riseRate":0.558824,"avgChangeRate":0.034845},{"month":9,"riseRate":0.575758,"avgChangeRate":0.032629},{"month":10,"riseRate":0.515152,"avgChangeRate":0.000869},{"month":11,"riseRate":0.636364,"avgChangeRate":0.039409},{"month":12,"riseRate":0.393939,"avgChangeRate":0.011167}],"exchange":"NASDAQ","name":"吉利德科学","nameEN":"Gilead Sciences"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.7","shortVersion":"4.34.7","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"吉利德科学(GILD)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供吉利德科学(GILD)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"吉利德科学,GILD,吉利德科学股票,吉利德科学股票老虎,吉利德科学股票老虎国际,吉利德科学行情,吉利德科学股票行情,吉利德科学股价,吉利德科学股市,吉利德科学股票价格,吉利德科学股票交易,吉利德科学股票购买,吉利德科学股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"吉利德科学(GILD)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供吉利德科学(GILD)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}